
Torrent Pharmaceuticalsm agreed to buy KKR’s 46% stake in rival JB Chemicals & Pharmaceuticals for 1.3 billion.
India’s drug regulator (CDSCO) proposes ending the easy bioequivalence-only route for new generic drugs, potentially mandating expensive clinical trials to…
Concerns remain as the treatment of chemical intermediates and patented medicines is still not clear
After months of hearings, the Delhi High Court delivered the landmark ruling which cleared the way for Natco Pharma to…
Indian pharma stocks, including Aurobindo Pharma and Lupin, surged after reports indicated the US Administration is considering excluding generic medicines…
Rubicon Research IPO opens with strong GMP premium; subscribe by Oct 13 to participate in this key pharma offering. Apply…
Pharma stocks rallied after reports suggested that the Trump administration may not impose tariffs on generic medicines.
India’s drug regulator, CDSCO, found serious failures in mandatory batch testing at drug facilities and issued an advisory to state…
Imported drugs could become more expensive for patients and healthcare providers if 100% tariffs get a go ahead.
Nomura warns Sun Pharma faces $100 million risk from potential US tariffs on specialty drugs. Explore the impact on Indian…
Dividend stocks this week, September 28: Glenmark Pharma trades ex-dividend on Oct 3; watch for interim Rs 2.5 payout. Check…
Indian pharma stocks fell up to 7% in reaction to the US imposing a 100% tariff on imported branded and…
Donald Trump imposed new tariffs on imported pharmaceutical products. Check out his announcement.
Discover why Nomura predicts a 25% downside for Glenmark Pharma despite its new cancer drug deal—read their analysis before investing!
The US Treasury has sanctioned Indian nationals for supplying counterfeit fentanyl-laced pills that fueled America’s opioid crisis.
India’s GST reform has reduced tax on essential medicines from 12% to 5% and fully exempted 36 life-saving drugs. The…
India’s exports rose 6.7% to $35.1 bn in August 2025, while imports fell 10.1% to $61.6 bn, narrowing the trade…
Zydus Lifesciences has launched VaxiFlu, India’s first trivalent influenza vaccine for seasonal flu protection. The vaccine follows WHO’s 2025–26 guidelines…